ArticlePloS one2021

Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy.

Hassan Issafras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.